SEVERANCE AGREEMENTSeverance Agreement • March 22nd, 2013 • Cell Therapeutics Inc • Pharmaceutical preparations • California
This SEVERANCE AGREEMENT (the “Agreement”) is entered into by and between Cell Therapeutics, Inc., a Washington corporation (“CTI” or the “Company”), and Matthew Plunkett (the “Executive”).
